Skip to main content
Caplight Logo









One Bio

One Bio

Private
Davis, CaliforniaHealthcare & Life Scienceshttps://www.one.bio/

Last Round

Series A

Dec 12, 2024

Total Funding Raised

$49.12M

Company Overview

One Bio is a biotechnology company that develops naturally-derived oligosaccharides from plant fibers designed for food, agriculture, and biopharmaceutical applications to support microbiome health and immune function.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Sustainable Materials, D2C Brands

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service, Usage-Based SaaS

AI Layer

Application

Keywords

functional fibergut healthmicrobiomeprebioticfiber discoveryfood techbiotechnologymetabolic healthingredient licensingbiohackingnext-gen nutritionpersonalized nutritionfood innovationnutraceuticals

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

One Bio Comparables

Compare One Bio with similar companies based on industry and business-model similarity.

One Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Brightseed
84%
Carbiotix
77%
BIOHM Health
74%

One Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ADec 12, 2024
Series AApr 13, 2022
GrantDec 1, 2021
SeedNov 1, 2020
SeedJan 1, 2020
Grant
Oct 21, 2019

Key People

Founding team and executive leadership

Matt Barnard

Cofounder CEO

Founding Team

Julie Wurfel

COO

Executive Team

One Bio Investors

Notable investors and investment history

One Bio investors
InvestorRounds
Morado VenturesSeries A
Better VenturesSeries A
iSelect FundSeries A, Seed
Skyviews Life ScienceSeries A
Gates FoundationGrant
Acre Venture PartnersSeries A
Collaborative FundSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 12, 2024

    $27M round led by Alpha Edison.

  • Apr 13, 2022

    $12M round led by Acre Venture Partners.

One Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

One Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about One Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersDavis, California
Employee Range39
Year Founded2019
Last FundingDec 12, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?